DCR:扩大右侧结肠切除术不会降低结肠癌局部区域复发的风险

2022-04-22 xuyihan MedSci原创

右半结肠切除范围,若对盲肠及升结肠癌,应同时切除回肠末端15cm、盲肠、升结肠、横结肠右半部及部分大网膜和胃网膜血管;切断及切除回盲动脉、右结肠动脉、中结肠动脉右支及其伴随的淋巴结。

右侧结肠癌(RSCC)的切除术已经成为结肠癌治疗的标准手术方式,随着时间的推移,手术技术也有了许多改进,使得直肠癌患者的短期和长期疗效都得到了改善。传统的右半结肠切除术(CRHC)是指切除右结肠,结肠癌患者在初次治疗后容易出现局部区域性复发,其总体生存率一般较低。因此,右半结肠扩大切除术是否是促进生存率提高的因素之一,目前仍有争议。本研究的目的是探究与传统方法相比,扩大手术切除结肠系膜的短期和长期结果差异。

 

这是一项基于前瞻性维护的丹麦结直肠癌组数据库的回顾性研究。主要观察结局指标是接受右侧结肠癌根治性切除术的患者的局部区域复发情况,次要结局指标是术后 30 天并发症。研究人员还研究了远处转移、非计划的术中不良事件以及术后 30 天和 90 天的死亡率。

 

研究结果显示在 12855 名切除右侧结肠癌的患者中,1151 名接受了扩大的右半结肠切除术。扩大右半结肠切除术的患者是 ASA 评分较低的年轻男性,由结直肠外科医生使用腹腔镜方法进行手术,并且淋巴结数量显着增加。局部区域复发率为 1.1% (136/12,855),常规右半结肠切除术与扩大右半结肠切除术之间没有差异 (OR 1.7 CI 95% 0.63-2.18)。即使在调整了年龄、合并症、腹部和其他协变量后,扩大右半结肠切除术的术后内科并发症也显着增加(OR 1.26 CI 95% 1.01-1.58)。

图:手术方式示意图

 

本项研究表明,在传统的右半结肠切除术和扩大的右半结肠切除术以及肠系膜切除术和中结肠血管结扎术之间,右侧结肠癌的局部区域复发没有差异,但是扩大切除与较高的术后并发症发生率相关。

 

 

原始出处:

El-Hussuna, Alaa. Et al. Extended Right-Sided Colon Resection Does Not Reduce the Risk of Colon Cancer Local-Regional Recurrence: Nationwide Population-Based Study from Danish Colorectal Cancer Group Database. Diseases of the Colon & Rectum.2022.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1706575, encodeId=a7761e0657542, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Sun Oct 16 10:52:19 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877577, encodeId=9ef218e75770d, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Jan 25 10:52:19 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406181, encodeId=74c714061812c, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Sun Apr 24 10:52:19 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213781, encodeId=dc6b1213e81f4, content=好紧张继续继续小惊喜你那, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fdb6533655, createdName=ms7000001105543453, createdTime=Sat Apr 23 23:17:31 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1706575, encodeId=a7761e0657542, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Sun Oct 16 10:52:19 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877577, encodeId=9ef218e75770d, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Jan 25 10:52:19 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406181, encodeId=74c714061812c, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Sun Apr 24 10:52:19 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213781, encodeId=dc6b1213e81f4, content=好紧张继续继续小惊喜你那, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fdb6533655, createdName=ms7000001105543453, createdTime=Sat Apr 23 23:17:31 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1706575, encodeId=a7761e0657542, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Sun Oct 16 10:52:19 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877577, encodeId=9ef218e75770d, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Jan 25 10:52:19 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406181, encodeId=74c714061812c, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Sun Apr 24 10:52:19 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213781, encodeId=dc6b1213e81f4, content=好紧张继续继续小惊喜你那, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fdb6533655, createdName=ms7000001105543453, createdTime=Sat Apr 23 23:17:31 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
    2022-04-24 chg122
  4. [GetPortalCommentsPageByObjectIdResponse(id=1706575, encodeId=a7761e0657542, content=<a href='/topic/show?id=0df2e87477d' target=_blank style='color:#2F92EE;'>#结肠切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78747, encryptionId=0df2e87477d, topicName=结肠切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a89f31292094, createdName=12498568m60暂无昵称, createdTime=Sun Oct 16 10:52:19 CST 2022, time=2022-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1877577, encodeId=9ef218e75770d, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Wed Jan 25 10:52:19 CST 2023, time=2023-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406181, encodeId=74c714061812c, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Sun Apr 24 10:52:19 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213781, encodeId=dc6b1213e81f4, content=好紧张继续继续小惊喜你那, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fdb6533655, createdName=ms7000001105543453, createdTime=Sat Apr 23 23:17:31 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
    2022-04-23 ms7000001105543453

    好紧张继续继续小惊喜你那

    0

相关资讯

JAAD:银屑病停用全身性类固醇后的红斑和反弹现象研究

有些研究认为银屑病患者应避免使用全身性类固醇,因为可能会出现反弹性脓疱性红斑,这篇综述发现,尽管皮损复发是常见的,但在逐渐减少/停止类固醇治疗后,反弹红斑的发生率很低。

Epilepsia:丘脑功能连接可预测停用抗癫痫药后癫痫复发

该研究确定了有或无癫痫复发的患者在停用抗癫痫药时丘脑皮层功能连接的明显特征,显示出其在停用抗癫痫药后预测癫痫发作结局的潜力。

Eur Urol Oncol:膀胱内VPM1002BC治疗常规BCG治疗后的非肌层浸润性膀胱癌(NMIBC)复发

调查了膀胱内注射VPM1002BC治疗常规卡介苗治疗后,复发的非肌肉浸润性膀胱癌(NMIBC)的疗效、安全性、耐受性和生活质量情况。

一出手即降低肝细胞癌术后1、3、5年复发风险近8成!这个“神药”是真全能!

研究表明,他汀类药物的使用与肝手术后肝细胞癌复发的减少有关

AP&T:克罗恩病患者的新末端回肠的疾病复发预示着严重内镜疾病进展的风险更高

炎症性肠病是一类多种病因引起的异常免疫介导的肠道慢性及复发性炎症,有终生复发倾向,溃疡性结肠炎和克罗恩病是其主要疾病类型。

BMC Gastroenterology: 结直肠癌根治性术后患者疾病复发的危险因素

结肠癌是常见的发生于结肠部位的消化道恶性肿瘤,结肠癌与人们食用红肉(如牛肉)有着很大的相关性。